Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuxue Tongluo for Capecitabine-Related Hand-Foot Syndrome
NCT07883642Phase 1Not yet recruiting
- Sponsor
- Emeishan Hospital of Traditional Chinese Medicine
- Start
- Oct 2026
- Primary completion
- Oct 2026
01
Overview
Phase 1, randomised, open-label trial in hand-foot syndrome (HFS) (2 arms), sponsored by Emeishan Hospital of Traditional Chinese Medicine. Primary endpoint: Proportion of patients with a >=1-grade reduction in Hand-Foot Syndrome score at 3 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
hand-foot syndrome (HFS)
Beyond the preview
Go deeper on NCT07883642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07883642.